A detailed history of Northern Trust Corp transactions in Zomedica Corp. stock. As of the latest transaction made, Northern Trust Corp holds 1,797,902 shares of ZOM stock, worth $233,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,797,902
Previous 1,797,902 -0.0%
Holding current value
$233,727
Previous $269,000 6.69%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.12 - $0.18 $57 - $86
-483 Reduced 0.03%
1,797,902 $269,000
Q1 2024

May 14, 2024

SELL
$0.12 - $0.19 $321 - $508
-2,676 Reduced 0.15%
1,798,385 $269,000
Q4 2023

Feb 13, 2024

BUY
$0.15 - $0.22 $1,973 - $2,893
13,154 Added 0.74%
1,801,061 $360,000
Q3 2023

Nov 13, 2023

BUY
$0.16 - $0.23 $3,672 - $5,279
22,954 Added 1.3%
1,787,907 $303,000
Q2 2023

Aug 11, 2023

SELL
$0.19 - $0.22 $1,083 - $1,254
-5,702 Reduced 0.32%
1,764,953 $352,000
Q1 2023

May 15, 2023

BUY
$0.16 - $0.29 $14,624 - $26,507
91,406 Added 5.44%
1,770,655 $371,000
Q2 2022

Aug 12, 2022

SELL
$0.2 - $0.34 $104,911 - $178,349
-524,557 Reduced 23.8%
1,679,249 $369,000
Q1 2022

May 13, 2022

SELL
$0.28 - $0.4 $11,348 - $16,212
-40,530 Reduced 1.81%
2,203,806 $743,000
Q4 2021

Feb 08, 2022

BUY
$0.31 - $0.58 $4,937 - $9,238
15,929 Added 0.71%
2,244,336 $687,000
Q3 2021

Nov 15, 2021

BUY
$0.46 - $0.81 $32,545 - $57,309
70,752 Added 3.28%
2,228,407 $1.17 Million
Q2 2021

Aug 13, 2021

BUY
$0.72 - $1.46 $187,950 - $381,122
261,043 Added 13.76%
2,157,655 $1.8 Million
Q1 2021

May 12, 2021

BUY
$0.35 - $2.7 $369,043 - $2.85 Million
1,054,409 Added 125.2%
1,896,612 $3 Million
Q4 2020

Feb 11, 2021

BUY
$0.07 - $0.25 $58,954 - $210,550
842,203 New
842,203 $195,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.